1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsProvides funding for startups and SMEs with innovative products or services that could create new markets or disrupt existing ones, including in AI and cybersecurity.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Startups and SMEs from EU Member States and Horizon Europe associated countries; small mid-caps may apply for the equity component only. Confirm the full requirements in the official notice before applying.
The current listing shows €2.5 million grant + €1–10 million equity investment. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for EIC Accelerator Open 2025/2026 are due November 4, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
EIC Accelerator Open 2025/2026 is funded by European Innovation Council (EIC), European Commission. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Merck Stimulating Innovative Research Grant Program 2026 includes a dedicated grant topic for artificial intelligence in cell culture media and process development, offering up to EUR 150,000 per year for up to 3 years. The program accelerates innovation through collaborative research, early engagement with industry experts, and translation of novel ideas into practical solutions. In 2026, priority areas also include in-vitro models for neuroinflammatory diseases (EUR 250,000/year for 2 years) and innovative approaches to contaminated materials remediation (EUR 150,000/year for 2 years). The two-stage application process begins with non-confidential submissions, followed by deep-dive workshops where finalists collaborate with Merck scientists and managers to jointly optimize proposals. The AI-specific grant focuses on applying machine learning and AI to optimize cell culture media formulation, bioprocess parameter optimization, and manufacturing quality control.
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed. Funding Opportunity Number: HT942526DMDRPIDA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $2.5M total program funding.
The FY2026 Bus Safety, Accessibility, and Innovation Research Program closes September 28. Universities, agencies, and startups are all eligible to lead — but every team must include a transit vehicle manufacturer in a prominent role, and FTA already cancelled a nearly identical NOFO in 2024 without making a single award.
Read articleThe FY2026 Agriculture Innovation Center Demonstration Program posted September 9 with a January 31, 2027 deadline. It is the first competition under a rule codified in 2024, the award floor is $600,000, and the single most common way to lose is to upload your application to Grants.gov.
Read articleThe Public Wireless Supply Chain Innovation Fund started at $1.5 billion for open RAN. Congress rescinded $850 million, NTIA canceled Round 3, and what remains is a $53 million final round pointed at AI-native radio access networks — with a $25 million per-project ceiling, a mandatory 50 percent cost share, and rolling awards beginning this fall.
Read article